Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7594551rdf:typepubmed:Citationlld:pubmed
pubmed-article:7594551lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0021758lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0085295lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0214743lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C1721046lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0312862lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C1522240lld:lifeskim
pubmed-article:7594551lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7594551pubmed:issue11lld:pubmed
pubmed-article:7594551pubmed:dateCreated1995-12-28lld:pubmed
pubmed-article:7594551pubmed:abstractTextThe human cytokine growth-regulated oncogene (GRO)-alpha is a small glycoprotein secreted by monocytes, endothelial cells, glycoprotein secreted by monocytes, endothelial cells, fibroblasts, synovial cells, and some tumor cells such as melanoma cells. It is structurally related to IL-8 and can activate neutrophils, whereas it induces chemotaxis, exocytosis, and a respiratory burst in neutrophils. To date, its functions on T lymphocytes have not been well established. We report here that recombinant human (rh)GRO-alpha is a potent chemoattractant for freshly isolated T lymphocytes, but not for anti-CD3 mAb-activated T lymphocytes. It attracts CD4+ and CD8+ T lymphocyte subsets to an equal extent. The migrating T lymphocytes toward rhGRO-alpha are predominantly CD45RO+ memory CD4+ and CD8+ subsets. The chemotactic migration of T lymphocytes toward rhGRO-alpha is stimulated via the IL-8 receptors on the cells. This process can be augmented by IFN-gamma and TNF-alpha, and inhibited by IL-4, IL-10, and IL-13. In addition, we also document that on T lymphocytes there exist IL-8 receptors that can be up-regulated by IFN-gamma, TNF-alpha, and IL-2. Our results demonstrate that rhGRO-alpha gene encodes for an inflammatory mediator that stimulates the directional migration of T lymphocytes. It may thus be another important mediator in the diseases in which T lymphocytes form the major constituent of the cellular infiltration.lld:pubmed
pubmed-article:7594551pubmed:languageenglld:pubmed
pubmed-article:7594551pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7594551pubmed:statusMEDLINElld:pubmed
pubmed-article:7594551pubmed:monthDeclld:pubmed
pubmed-article:7594551pubmed:issn0022-1767lld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:Thestrup-Pede...lld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:MatsushimaKKlld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:BondeJJlld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:JinquanTTlld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:MukaidaNNlld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:LarsenC GCGlld:pubmed
pubmed-article:7594551pubmed:authorpubmed-author:FrydenbergJJlld:pubmed
pubmed-article:7594551pubmed:issnTypePrintlld:pubmed
pubmed-article:7594551pubmed:day1lld:pubmed
pubmed-article:7594551pubmed:volume155lld:pubmed
pubmed-article:7594551pubmed:ownerNLMlld:pubmed
pubmed-article:7594551pubmed:authorsCompleteYlld:pubmed
pubmed-article:7594551pubmed:pagination5359-68lld:pubmed
pubmed-article:7594551pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:meshHeadingpubmed-meshheading:7594551-...lld:pubmed
pubmed-article:7594551pubmed:year1995lld:pubmed
pubmed-article:7594551pubmed:articleTitleRecombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13.lld:pubmed
pubmed-article:7594551pubmed:affiliationDepartment of Dermatology, University of Aarhus, Denmark.lld:pubmed
pubmed-article:7594551pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7594551pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7594551lld:pubmed